Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Borax Français, a subsidiary of Rio Tinto, is a leading manufacturer and refiner of high-quality boron-based chemicals, including borax and boric acid. Based in Coudekerque-Branche, France, the company specializes in producing high-purity borates tailored for the pharmaceutical, agricultural, and industrial sectors. In the healthcare industry, its products are utilized as essential excipients, buffering agents, and active ingredients in ophthalmic and topical medications. Additionally, the company provides critical raw materials for the production of borosilicate glass, which is used extensively in medical vials and laboratory equipment. The facility operates under strict quality standards, maintaining certifications such as ISO 9001 and complying with international pharmacopoeia requirements. As the only borate refinery in Europe, Borax Français serves as a strategic supplier for the regional life sciences supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Borax Français.